Could oral antiviral pills be a game-changer for COVID-19? An infectious disease physician explains why these options are badly needed

Published on November 19, 2021

Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.

Continue reading on website
Other news

Tick management programs could help stop Lyme disease, but US funding is inadequate

November 19, 2021
Lyme disease affects millions worldwide. But there are things you can do to protect yourself from this insidious illness.

AdvanSix (ASIX) Shows Fast-paced Momentum But Is Still a Bargain Stock

November 19, 2021
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, AdvanSix (ASIX) could be a great choice. It is one of...